Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Smith & Nephew shares rally slightly despite a Deutsche Bank downgrade after results disappointment

The German bank’s analysts cut their stance on the FTSE 100-listed artificial hips and knees maker to ‘sell’ from ‘hold’ and reduced their target price to 1,200p from 1.315p

Smith & Nephew PLC (LON:SN.) shares edged higher on Friday following big falls after disappointing first-quarter results in the previous session, despite a downgrade in rating by Deutsche Bank.

The German bank’s analysts cut their stance on the FTSE 100-listed artificial hips and knees maker to ‘sell’ from ‘hold’ and reduced their target price for the stock to 1,200p from 1.315p.

READ: Smith & Nephew cuts full year revenue guidance after weaker first quarter

In a note to clients, they said: “We expect shares in S&N to de-rate from ~19x 1-yr fwd P/E to ~17x 1-yr fwd P/E.

“This reflects our view that the company can only deliver low single-digit earnings growth and that the visibility of this growth may reduce further.”

Smith & Nephew shares slumped by around 8% yesterday after it reported flat underlying revenue for the first three months of the year, well below analysts’ expectations for growth of 1.6%.

However, in late morning trading on Friday, the shares edged up 0.2% to 1,304.5p.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK